Anzeige
Meldung des Tages: Warum diese Aktie einer der großen Gewinner im neuen Goldzyklus sein könnte

MoonLake Immunotherapeutics Aktie News

Aktie
WKN:  A3DFA7 ISIN:  KY61559X1045 US-Symbol:  MLTX Branche:  Biotechnologie Land:  Schweiz
15,03 $
-0,34 $
-2,21%
12,731 € 20:59:51 Uhr
Depot/Watchlist
Marktkapitalisierung *
745,67 Mio. €
Streubesitz
28,79%
KGV
-28,65
Index-Zuordnung
-

MoonLake Immunotherapeutics News

26.11.25 - PR Newswire
MoonLake Immunotherapeutics' (MLTX) Stock Crashes 90%, Triggers Lawsuit After Reported Phase 3 Trial Data for Sole Drug Candidate -- Hagens Berman
MoonLake Immunotherapeutics' (MLTX) Stock Crashes 90%, Triggers Lawsuit After Reported Phase 3 Trial Data for Sole Drug Candidate -- Hagens Berman PR Newswire
25.11.25 - PR Newswire
MoonLake Immunotherapeutics' (MLTX) Reported Phase 3 Trial Data for Sole Drug Candidate, 90% Stock Crash Triggers Investor Suit -- Hagens Berman
MoonLake Immunotherapeutics' (MLTX) Reported Phase 3 Trial Data for Sole Drug Candidate, 90% Stock Crash Triggers Investor Suit -- Hagens Berman PR Newswire
25.11.25 - PR Newswire
MoonLake Immunotherapeutics Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX
MoonLake Immunotherapeutics Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX PR Newswire
24.11.25 - PR Newswire
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights - MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights - MLTX PR Newswire
24.11.25 - PR Newswire
INVESTOR ALERT: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Class Action by December 15, 2025
INVESTOR ALERT: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Class Action by December 15, 2025 PR ...
22.11.25 - PR Newswire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit PR Newswire
21.11.25 - PR Newswire
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
21.11.25 - PR Newswire
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics PR Newswire
21.11.25 - PR Newswire
MoonLake Immunotherapeutics Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MLTX PR Newswire
21.11.25 - PR Newswire
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX PR Newswire
21.11.25 - PR Newswire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
20.11.25 - PR Newswire
MLTX LAWSUIT ALERT: The Gross Law Firm Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline
MLTX LAWSUIT ALERT: The Gross Law Firm Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
18.11.25 - PR Newswire
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman PR ...
18.11.25 - PR Newswire
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
18.11.25 - PR Newswire
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX PR Newswire
17.11.25 - PR Newswire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit PR Newswire
17.11.25 - PR Newswire
MLTX DEADLINE REMINDER: Berger Montague Reminds MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors of Important Class Action Lawsuit Deadline
MLTX DEADLINE REMINDER: Berger Montague Reminds MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors of Important Class Action Lawsuit Deadline PR Newswire
17.11.25 - PR Newswire
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights - MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights - MLTX PR Newswire
14.11.25 - PR Newswire
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
14.11.25 - PR Newswire
Faruqi & Faruqi Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX
Faruqi & Faruqi Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX PR Newswire

Newssuche

Videos

newspaper
03.02.26
2026 02 03 17 34 Trendjumper Einführung
Zunächst inormieren wir unsere Stammkunden bezüglich des bevorstehenden Seminars und bieten für ... Mehr »